Early Diagnosis of Kidney Injury via Ultrasensitive Detection of Urine-Derived Exosomes Using a Dual-Signal Amplification Strategy
ACS Sensors · 2025
DOI: 10.1021/acssensors.5c00287 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2025. Verfasst von Yanyan Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Exosomes, Acute Kidney Injury, Lipocalin-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Henan Provincial Science and Technology Research and Development Plan Joint Fund.
Abstract (Originalsprache)
Kidney injury is one of the most serious health problems, including drug-induced acute kidney injury (AKI) and disease-induced chronic kidney disease. Neutrophil gelatinase-associated lipocalin (NGAL) carried by urinary exosomes (uExos) has emerged as a potential biomarker for the diagnosis of kidney injury. However, sensitive detection of urinary exosomal NGAL remains challenging due to its low abundance in urine during the early stages of kidney injury. In this study, we developed a highly sensitive uExos analysis platform by integrating deoxyribonuclease I (DNase I)-mediated biomarker cycling with a metal-enhanced fluorescence (MEF) effect for dual fluorescence signal amplification. This method achieved a remarkably low limit of detection (LOD) of 3.02 × 103 particles/mL, with a linear range from 5 × 103 to 2 × 1011 particles/mL. Using this approach, we successfully distinguished urine samples from diabetic nephropathy (DN) patients and healthy donors (HD) by analyzing the level of urinary exosomal NGAL. Moreover, in a rat model of cisplatin-induced AKI, our strategy detected abnormalities as early as 12 h postcisplatin injection─significantly earlier than conventional clinical biomarkers such as serum creatinine (sCr) and blood urea nitrogen (BUN). Additionally, this method demonstrated the potential for accurately evaluating the efficacy of anti-AKI therapeutics. In summary, the dual signal amplification strategy presented in this study facilitates early diagnosis of both chronic and acute kidney injury while offering a powerful tool for dynamically monitoring therapeutic responses in kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
- Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, Zhengzhou 450001, China.
ORCID-Profile: Yanyan Zhao, Junli Zhang
Förderung
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research and Development Plan Joint Fund
Zitieren
APA
Zhao, Y., Chang, W., Li, X., Su, P., Zhang, H., & Zhang, J. (2025). Early Diagnosis of Kidney Injury via Ultrasensitive Detection of Urine-Derived Exosomes Using a Dual-Signal Amplification Strategy. ACS Sensors. https://doi.org/10.1021/acssensors.5c00287
Vancouver
Zhao Y, Chang W, Li X, Su P, Zhang H, Zhang J. Early Diagnosis of Kidney Injury via Ultrasensitive Detection of Urine-Derived Exosomes Using a Dual-Signal Amplification Strategy. ACS Sensors. 2025. doi:10.1021/acssensors.5c00287
BibTeX
@article{Zhao2025,
author = {Zhao, Yanyan and Chang, Wenjia and Li, Xinru and Su, Peiyan and Zhang, Hongling and Zhang, Junli},
title = {Early Diagnosis of Kidney Injury via Ultrasensitive Detection of Urine-Derived Exosomes Using a Dual-Signal Amplification Strategy},
journal = {ACS Sensors},
year = {2025},
doi = {10.1021/acssensors.5c00287}
}
EUVIMED